CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹380 Cr | ₹21 Cr | ₹-55 Cr | ₹-109 Cr | ₹-146 Cr |
What is the latest Net Cash Inflow / Outflow ratio of CIPLA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹380 Cr |
| Mar2025 | ₹21 Cr |
| Mar2024 | ₹-55 Cr |
| Mar2023 | ₹-109 Cr |
| Mar2022 | ₹-146 Cr |
How is Net Cash Inflow / Outflow of CIPLA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹380 Cr | 1,706.37 | |
| Mar2025 | ₹21 Cr | Positive | |
| Mar2024 | ₹-55 Cr | Negative | |
| Mar2023 | ₹-109 Cr | Negative | |
| Mar2022 | ₹-146 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹118,847.6 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
| MANKIND PHARMA | ₹104,911.0 Cr | -0.3% | 7.9% | 8.4% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.4% |
5.3% |
-3% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses